Global Antiserum Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market by Type
  • 1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Antitoxin Serum
  • 1.2.3 Antibacterial Serum
  • 1.2.4 Antiviral Serum
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Clinical
  • 1.3.3 Laboratory
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Antiserum Market Perspective (2020-2031)
• 2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
• 2.3 Global Antiserum Revenue Market Share by Region (2020-2025)
• 2.4 Global Antiserum Revenue Forecast by Region (2026-2031)
• 2.5 Major Region and Emerging Market Analysis
  • 2.5.1 North America Antiserum Market Size and Prospective (2020-2031)
  • 2.5.2 Europe Antiserum Market Size and Prospective (2020-2031)
  • 2.5.3 China Antiserum Market Size and Prospective (2020-2031)
  • 2.5.4 Japan Antiserum Market Size and Prospective (2020-2031)
  • 2.5.5 India Antiserum Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

• 3.1 Global Antiserum Historic Market Size by Type (2020-2025)
• 3.2 Global Antiserum Forecasted Market Size by Type (2026-2031)
• 3.3 Different Types Antiserum Representative Players

4 Breakdown Data by Application

• 4.1 Global Antiserum Historic Market Size by Application (2020-2025)
• 4.2 Global Antiserum Forecasted Market Size by Application (2026-2031)
• 4.3 New Sources of Growth in Antiserum Application

5 Competition Landscape by Players

• 5.1 Global Top Players by Revenue
  • 5.1.1 Global Top Antiserum Players by Revenue (2020-2025)
  • 5.1.2 Global Antiserum Revenue Market Share by Players (2020-2025)
• 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 5.3 Players Covered: Ranking by Antiserum Revenue
• 5.4 Global Antiserum Market Concentration Analysis
  • 5.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
  • 5.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2024
• 5.5 Global Key Players of Antiserum Head office and Area Served
• 5.6 Global Key Players of Antiserum, Product and Application
• 5.7 Global Key Players of Antiserum, Date of Enter into This Industry
• 5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

• 6.1 North America Market: Players, Segments and Downstream
  • 6.1.1 North America Antiserum Revenue by Company (2020-2025)
  • 6.1.2 North America Market Size by Type
    • 6.1.2.1 North America Antiserum Market Size by Type (2020-2025)
    • 6.1.2.2 North America Antiserum Market Share by Type (2020-2025)
  • 6.1.3 North America Market Size by Application
    • 6.1.3.1 North America Antiserum Market Size by Application (2020-2025)
    • 6.1.3.2 North America Antiserum Market Share by Application (2020-2025)
  • 6.1.4 North America Market Trend and Opportunities
• 6.2 Europe Market: Players, Segments and Downstream
  • 6.2.1 Europe Antiserum Revenue by Company (2020-2025)
  • 6.2.2 Europe Market Size by Type
    • 6.2.2.1 Europe Antiserum Market Size by Type (2020-2025)
    • 6.2.2.2 Europe Antiserum Market Share by Type (2020-2025)
  • 6.2.3 Europe Market Size by Application
    • 6.2.3.1 Europe Antiserum Market Size by Application (2020-2025)
    • 6.2.3.2 Europe Antiserum Market Share by Application (2020-2025)
  • 6.2.4 Europe Market Trend and Opportunities
• 6.3 China Market: Players, Segments and Downstream
  • 6.3.1 China Antiserum Revenue by Company (2020-2025)
  • 6.3.2 China Market Size by Type
    • 6.3.2.1 China Antiserum Market Size by Type (2020-2025)
    • 6.3.2.2 China Antiserum Market Share by Type (2020-2025)
  • 6.3.3 China Market Size by Application
    • 6.3.3.1 China Antiserum Market Size by Application (2020-2025)
    • 6.3.3.2 China Antiserum Market Share by Application (2020-2025)
  • 6.3.4 China Market Trend and Opportunities
• 6.4 Japan Market: Players, Segments and Downstream
  • 6.4.1 Japan Antiserum Revenue by Company (2020-2025)
  • 6.4.2 Japan Market Size by Type
    • 6.4.2.1 Japan Antiserum Market Size by Type (2020-2025)
    • 6.4.2.2 Japan Antiserum Market Share by Type (2020-2025)
  • 6.4.3 Japan Market Size by Application
    • 6.4.3.1 Japan Antiserum Market Size by Application (2020-2025)
    • 6.4.3.2 Japan Antiserum Market Share by Application (2020-2025)
  • 6.4.4 Japan Market Trend and Opportunities
• 6.5 India Market: Players, Segments and Downstream
  • 6.5.1 India Antiserum Revenue by Company (2020-2025)
  • 6.5.2 India Market Size by Type
    • 6.5.2.1 India Antiserum Market Size by Type (2020-2025)
    • 6.5.2.2 India Antiserum Market Share by Type (2020-2025)
  • 6.5.3 India Market Size by Application
    • 6.5.3.1 India Antiserum Market Size by Application (2020-2025)
    • 6.5.3.2 India Antiserum Market Share by Application (2020-2025)
  • 6.5.4 India Market Trend and Opportunities

7 Key Players Profiles

• 7.1 CSL
  • 7.1.1 CSL Company Details
  • 7.1.2 CSL Business Overview
  • 7.1.3 CSL Antiserum Introduction
  • 7.1.4 CSL Revenue in Antiserum Business (2020-2025)
  • 7.1.5 CSL Recent Development
• 7.2 Merck
  • 7.2.1 Merck Company Details
  • 7.2.2 Merck Business Overview
  • 7.2.3 Merck Antiserum Introduction
  • 7.2.4 Merck Revenue in Antiserum Business (2020-2025)
  • 7.2.5 Merck Recent Development
• 7.3 BTG
  • 7.3.1 BTG Company Details
  • 7.3.2 BTG Business Overview
  • 7.3.3 BTG Antiserum Introduction
  • 7.3.4 BTG Revenue in Antiserum Business (2020-2025)
  • 7.3.5 BTG Recent Development
• 7.4 Pfizer
  • 7.4.1 Pfizer Company Details
  • 7.4.2 Pfizer Business Overview
  • 7.4.3 Pfizer Antiserum Introduction
  • 7.4.4 Pfizer Revenue in Antiserum Business (2020-2025)
  • 7.4.5 Pfizer Recent Development
• 7.5 CNBG
  • 7.5.1 CNBG Company Details
  • 7.5.2 CNBG Business Overview
  • 7.5.3 CNBG Antiserum Introduction
  • 7.5.4 CNBG Revenue in Antiserum Business (2020-2025)
  • 7.5.5 CNBG Recent Development
• 7.6 Bharat Serums and Vaccines
  • 7.6.1 Bharat Serums and Vaccines Company Details
  • 7.6.2 Bharat Serums and Vaccines Business Overview
  • 7.6.3 Bharat Serums and Vaccines Antiserum Introduction
  • 7.6.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025)
  • 7.6.5 Bharat Serums and Vaccines Recent Development
• 7.7 Haffkine Bio-Pharmaceutical
  • 7.7.1 Haffkine Bio-Pharmaceutical Company Details
  • 7.7.2 Haffkine Bio-Pharmaceutical Business Overview
  • 7.7.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
  • 7.7.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025)
  • 7.7.5 Haffkine Bio-Pharmaceutical Recent Development
• 7.8 Serum Biotech
  • 7.8.1 Serum Biotech Company Details
  • 7.8.2 Serum Biotech Business Overview
  • 7.8.3 Serum Biotech Antiserum Introduction
  • 7.8.4 Serum Biotech Revenue in Antiserum Business (2020-2025)
  • 7.8.5 Serum Biotech Recent Development
• 7.9 Bio-Rad
  • 7.9.1 Bio-Rad Company Details
  • 7.9.2 Bio-Rad Business Overview
  • 7.9.3 Bio-Rad Antiserum Introduction
  • 7.9.4 Bio-Rad Revenue in Antiserum Business (2020-2025)
  • 7.9.5 Bio-Rad Recent Development
• 7.10 BD
  • 7.10.1 BD Company Details
  • 7.10.2 BD Business Overview
  • 7.10.3 BD Antiserum Introduction
  • 7.10.4 BD Revenue in Antiserum Business (2020-2025)
  • 7.10.5 BD Recent Development
• 7.11 Vins Bioproducts
  • 7.11.1 Vins Bioproducts Company Details
  • 7.11.2 Vins Bioproducts Business Overview
  • 7.11.3 Vins Bioproducts Antiserum Introduction
  • 7.11.4 Vins Bioproducts Revenue in Antiserum Business (2020-2025)
  • 7.11.5 Vins Bioproducts Recent Development
• 7.12 FUJIFILM Wako Pure Chemical Corporation
  • 7.12.1 FUJIFILM Wako Pure Chemical Corporation Company Details
  • 7.12.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
  • 7.12.3 FUJIFILM Wako Pure Chemical Corporation Antiserum Introduction
  • 7.12.4 FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2020-2025)
  • 7.12.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
• 7.13 SSI Diagnostica
  • 7.13.1 SSI Diagnostica Company Details
  • 7.13.2 SSI Diagnostica Business Overview
  • 7.13.3 SSI Diagnostica Antiserum Introduction
  • 7.13.4 SSI Diagnostica Revenue in Antiserum Business (2020-2025)
  • 7.13.5 SSI Diagnostica Recent Development
• 7.14 GD Animal Health
  • 7.14.1 GD Animal Health Company Details
  • 7.14.2 GD Animal Health Business Overview
  • 7.14.3 GD Animal Health Antiserum Introduction
  • 7.14.4 GD Animal Health Revenue in Antiserum Business (2020-2025)
  • 7.14.5 GD Animal Health Recent Development

8 Antiserum Market Dynamics

• 8.1 Antiserum Industry Trends
• 8.2 Antiserum Market Drivers
• 8.3 Antiserum Market Challenges
• 8.4 Antiserum Market Restraints

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer

List of Tables

Table 1. Global Antiserum Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Antiserum Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Antiserum Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Antiserum Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Antiserum Revenue Share by Region (2020-2025)

Table 6. Global Antiserum Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Antiserum Revenue Share Forecast by Region (2026-2031)

Table 8. Global Antiserum Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Antiserum Revenue Market Share by Type (2020-2025)

Table 10. Global Antiserum Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Antiserum Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Antiserum Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Antiserum Revenue Market Share by Application (2020-2025)

Table 15. Global Antiserum Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Antiserum Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Antiserum Application

Table 18. Global Antiserum Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Antiserum Market Share by Players (2020-2025)

Table 20. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2024)

Table 21. Ranking of Global Top Antiserum Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Antiserum Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Antiserum, Headquarters and Area Served

Table 24. Global Key Players of Antiserum, Product and Application

Table 25. Global Key Players of Antiserum, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Antiserum Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Antiserum Revenue Market Share by Company (2020-2025)

Table 29. North America Antiserum Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Antiserum Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Antiserum Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Antiserum Revenue Market Share by Company (2020-2025)

Table 33. Europe Antiserum Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Antiserum Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Antiserum Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Antiserum Revenue Market Share by Company (2020-2025)

Table 37. China Antiserum Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Antiserum Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Antiserum Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Antiserum Revenue Market Share by Company (2020-2025)

Table 41. Japan Antiserum Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Antiserum Market Size by Application (2020-2025) & (US$ Million)

Table 43. India Antiserum Revenue by Company (2020-2025) & (US$ Million)

Table 44. India Antiserum Revenue Market Share by Company (2020-2025)

Table 45. India Antiserum Market Size by Type (2020-2025) & (US$ Million)

Table 46. India Antiserum Market Size by Application (2020-2025) & (US$ Million)

Table 47. CSL Company Details

Table 48. CSL Business Overview

Table 49. CSL Antiserum Product

Table 50. CSL Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 51. CSL Recent Development

Table 52. Merck Company Details

Table 53. Merck Business Overview

Table 54. Merck Antiserum Product

Table 55. Merck Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 56. Merck Recent Development

Table 57. BTG Company Details

Table 58. BTG Business Overview

Table 59. BTG Antiserum Product

Table 60. BTG Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 61. BTG Recent Development

Table 62. Pfizer Company Details

Table 63. Pfizer Business Overview

Table 64. Pfizer Antiserum Product

Table 65. Pfizer Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 66. Pfizer Recent Development

Table 67. CNBG Company Details

Table 68. CNBG Business Overview

Table 69. CNBG Antiserum Product

Table 70. CNBG Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 71. CNBG Recent Development

Table 72. Bharat Serums and Vaccines Company Details

Table 73. Bharat Serums and Vaccines Business Overview

Table 74. Bharat Serums and Vaccines Antiserum Product

Table 75. Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 76. Bharat Serums and Vaccines Recent Development

Table 77. Haffkine Bio-Pharmaceutical Company Details

Table 78. Haffkine Bio-Pharmaceutical Business Overview

Table 79. Haffkine Bio-Pharmaceutical Antiserum Product

Table 80. Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 81. Haffkine Bio-Pharmaceutical Recent Development

Table 82. Serum Biotech Company Details

Table 83. Serum Biotech Business Overview

Table 84. Serum Biotech Antiserum Product

Table 85. Serum Biotech Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 86. Serum Biotech Recent Development

Table 87. Bio-Rad Company Details

Table 88. Bio-Rad Business Overview

Table 89. Bio-Rad Antiserum Product

Table 90. Bio-Rad Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 91. Bio-Rad Recent Development

Table 92. BD Company Details

Table 93. BD Business Overview

Table 94. BD Antiserum Product

Table 95. BD Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 96. BD Recent Development

Table 97. Vins Bioproducts Company Details

Table 98. Vins Bioproducts Business Overview

Table 99. Vins Bioproducts Antiserum Product

Table 100. Vins Bioproducts Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 101. Vins Bioproducts Recent Development

Table 102. FUJIFILM Wako Pure Chemical Corporation Company Details

Table 103. FUJIFILM Wako Pure Chemical Corporation Business Overview

Table 104. FUJIFILM Wako Pure Chemical Corporation Antiserum Product

Table 105. FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 106. FUJIFILM Wako Pure Chemical Corporation Recent Development

Table 107. SSI Diagnostica Company Details

Table 108. SSI Diagnostica Business Overview

Table 109. SSI Diagnostica Antiserum Product

Table 110. SSI Diagnostica Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 111. SSI Diagnostica Recent Development

Table 112. GD Animal Health Company Details

Table 113. GD Animal Health Business Overview

Table 114. GD Animal Health Antiserum Product

Table 115. GD Animal Health Revenue in Antiserum Business (2020-2025) & (US$ Million)

Table 116. GD Animal Health Recent Development

Table 117. Antiserum Market Trends

Table 118. Antiserum Market Drivers

Table 119. Antiserum Market Challenges

Table 120. Antiserum Market Restraints

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Antiserum Product Picture

Figure 2. Global Antiserum Market Share by Type: 2024 VS 2031

Figure 3. Antitoxin Serum Features

Figure 4. Antibacterial Serum Features

Figure 5. Antiviral Serum Features

Figure 6. Others Features

Figure 7. Global Antiserum Market Share by Application: 2024 VS 2031

Figure 8. Clinical

Figure 9. Laboratory

Figure 10. Antiserum Report Years Considered

Figure 11. Global Antiserum Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Antiserum Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Antiserum Revenue Market Share by Region: 2020 VS 2024

Figure 14. North America Antiserum Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. Europe Antiserum Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. China Antiserum Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Japan Antiserum Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. India Antiserum Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Global Antiserum Market Share by Players in 2024

Figure 20. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2024

Figure 22. North America Antiserum Market Share by Type (2020-2025)

Figure 23. North America Antiserum Market Share by Application (2020-2025)

Figure 24. Europe Antiserum Market Share by Type (2020-2025)

Figure 25. Europe Antiserum Market Share by Application (2020-2025)

Figure 26. China Antiserum Market Share by Type (2020-2025)

Figure 27. China Antiserum Market Share by Application (2020-2025)

Figure 28. Japan Antiserum Market Share by Type (2020-2025)

Figure 29. Japan Antiserum Market Share by Application (2020-2025)

Figure 30. India Antiserum Market Share by Type (2020-2025)

Figure 31. India Antiserum Market Share by Application (2020-2025)

Figure 32. CSL Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 33. Merck Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 34. BTG Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 35. Pfizer Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 36. CNBG Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 37. Bharat Serums and Vaccines Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 38. Haffkine Bio-Pharmaceutical Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 39. Serum Biotech Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 40. Bio-Rad Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 41. BD Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 42. Vins Bioproducts Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 43. FUJIFILM Wako Pure Chemical Corporation Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 44. SSI Diagnostica Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 45. GD Animal Health Revenue Growth Rate in Antiserum Business (2020-2025)

Figure 46. Bottom-up and Top-down Approaches for This Report

Figure 47. Data Triangulation

Figure 48. Key Executives Interviewed